Skip to content
DeepViews

Ardent Health, Inc. (ARDT) — Analysis Summary

Ardent Health, Inc. (ARDT) has a market cap of $1.63B with year-over-year revenue growth of +6.0%. Net margin stands at 2.1%. The stock trades at a P/E ratio of 20.8.

Key Takeaways

  • Revenue changed +6.0% year-over-year
  • Net margin of 2.1%
  • P/E ratio of 20.8

Compared to other companies in the SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC sector, ARDT posted revenue growth of +6.0% and trades at a P/E of 20.8.

[XNYS]

Ardent Health, Inc. (ARDT)

$11.53

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$1626.26M
Enterprise Value
$2003.57M
P/E Ratio
20.8
Div Yield
0.00%
EV/EBITDA
6.0
Company Profile
About
About Ardent Health, Inc.

Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.

Sector

SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC

Employees

25,200

Headquarters

BRENTWOOD, TN

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat

At least 3 years of annual financial data required to assess competitive moat.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$1741.40M
Total Debt$1101.78M
Debt-to-Equity0.63
Cash & Equivalents$724.48M

Cash Flow

Operating Cash Flow$514.32M
Free Cash Flow$0.00M
FCF Margin0.00%
P/FCF RatioN/A
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.